Source: Neuroimmunomodulation. Unidades: FCF, ICB, FMVZ
Subjects: INFLAMAÇÃO, DROGAS DE ABUSO, LEUCÓCITOS, FÁRMACOS SINTÉTICOS
ABNT
STANKEVICIUS, Daniel et al. 3,4-Methylenedioxymethamphetamine (Ecstasy) decreases inflammation and airway reactivity in a murine model of asthma. Neuroimmunomodulation, v. 19, n. 4, p. 209-219, 2012Tradução . . Disponível em: https://doi.org/10.1159/000334098. Acesso em: 15 out. 2024.APA
Stankevicius, D., Ferraz de Paula, V., Ribeiro, A., Pinheiro, M. L., Oliveira, A. P. L. de, Damazo, A. S., et al. (2012). 3,4-Methylenedioxymethamphetamine (Ecstasy) decreases inflammation and airway reactivity in a murine model of asthma. Neuroimmunomodulation, 19( 4), 209-219. doi:10.1159/000334098NLM
Stankevicius D, Ferraz de Paula V, Ribeiro A, Pinheiro ML, Oliveira APL de, Damazo AS, Lapachinske SF, Moreau RL de M, Lima WT de, Palermo-Neto J. 3,4-Methylenedioxymethamphetamine (Ecstasy) decreases inflammation and airway reactivity in a murine model of asthma [Internet]. Neuroimmunomodulation. 2012 ; 19( 4): 209-219.[citado 2024 out. 15 ] Available from: https://doi.org/10.1159/000334098Vancouver
Stankevicius D, Ferraz de Paula V, Ribeiro A, Pinheiro ML, Oliveira APL de, Damazo AS, Lapachinske SF, Moreau RL de M, Lima WT de, Palermo-Neto J. 3,4-Methylenedioxymethamphetamine (Ecstasy) decreases inflammation and airway reactivity in a murine model of asthma [Internet]. Neuroimmunomodulation. 2012 ; 19( 4): 209-219.[citado 2024 out. 15 ] Available from: https://doi.org/10.1159/000334098